首页 | 本学科首页   官方微博 | 高级检索  
     


Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment
Authors:Hongjie Yu PhD  Zhuqing Shi PhD  Xiaoling Lin PhD  Quanwa Bao BD  Haifei Jia MD  Jun Wei PhD  Brian T. Helfand MD  PhD  Siqun. L. Zheng MD  David Duggan PhD  Daru Lu PhD  Zengnan Mo PhD  Jianfeng Xu MD  DrPH
Affiliation:1. Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois;2. Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China;3. State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China;4. Translational Genomics Research Institute, An Affiliate of City of Hope, Phoenix, Arizona;5. Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China
Abstract:
Keywords:clinical validity  genetic risk score  prostate cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号